HIV: Clinical manifestations

Journal of Allergy and Clinical Immunology

Volumn 110, Issue 1, 2002, Pages 3-16

  Moylett, Edina H ^a   Shearer, William T ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

AIDS; Clinical manifestations; Highly active antiretroviral therapy; HIV; Opportunistic infections

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CD4 ANTIGEN; CHYLOMICRON; CYTOCHROME P450; PROTEINASE INHIBITOR; STAVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; BARTONELLA HENSELAE; BARTONELLA QUINTANA; BONE MARROW SUPPRESSION; CANDIDIASIS; CELL COUNT; CLINICAL FEATURE; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS; DISEASE ACTIVITY; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DYSPHAGIA; ENCEPHALITIS; GLOMERULOSCLEROSIS; HEART DISEASE; HERPES SIMPLEX VIRUS; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INCUBATION TIME; INFECTION RATE; KAPOSI SARCOMA; LUNG INFECTION; METABOLIC DISORDER; MOUTH LESION; MYCOSIS; NEOPLASM; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEIN BINDING; PSEUDOMONAS AERUGINOSA; REVIEW; RHEUMATOID ARTHRITIS; SEROCONVERSION; SKIN DEFECT; SKIN DISEASE; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

EID: 0036968464     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.125978     Document Type: Review

References (81)

1. Lavreys L, Thompson ML, Martin HL Jr, Mandaliya K, Ndinya-Achola JO, Bwayo JJ, et al. Primary human immunodeficiency virus type 1 infection: clinical manifestations among women in Mombasa, Kenya. Clin Infect Dis 2000;30:486-90.
2. Cooper DA, Gold J, Maclean P, Donovan B, Finlayson R, Barnes TG, et al. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet 1985;1:537-40.
3. Tindall B, Barker S, Donovan B, Barnes T, Roberts J, Kronenberg C, et al. Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med 1988;148:945-9.
4. Pedersen C, Lindhardt BO, Jensen BL, Lauritzen E, Gerstoft J, Dickmeiss E, et al. Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ 1989;299:154-7.
5. Valle SL. Febrile pharyngitis as the primary sign of HIV infection in a cluster of cases linked by sexual contact. Scand J Infect Dis 1987;19:13-7.
6. Schacker T, Collier AC, Hughes J, Shea T, Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996;125:257-64.
7. Gaines H, von Sydow M, Pehrson PO, Lundbegh P. Clinical picture of primary HIV infection presenting as a glandular-fever-like illness. BMJ 1988;297:1363-8.
8. Vanhems P, Allard R, Cooper DA, Perrin L, Vizzard J, Hirschel B, et al. Human immunodeficiency vires type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive? Clin Infect Dis 1997;24:965-70.
9. Rustin MH. Ridley CM, Smith MD, Kelsey MC, Parker N. The acute exanthem associated with seroconversion to human T-cell lymphotropic virus III in a homosexual man. J Infect 1986;12:161-3.
10. Ho DD, Sarngadharan MG, Resnick L, Dimarzoveronese F, Rota TR, Hirsch MS. Primary human T-lymphotrophic virus type III infection. Ann Intern Med 1985;103:800-3.
11. Lewis DA, Brook MG. Erythema multiforme as a presentation of human immunodeficiency virus seroconversion illness. Int J STD AIDS 1992;3:56-7.
12. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-1989. A 26-year-old woman with fever, diarrhea, leukopenia, thrombocytopenia and hypoxemia. N Engl J Med 1989;321:454-63.
13. Kinloch-de Loës S, de Saussure P, Saurat JH, Stalder H, Hirschel B, Perrin LH. Symptomatic primary, infection due to human immunodeficiency virus type 1: review of 31 cases. Clin Infect Dis 1993;17:59-65.
14. Rabeneck L, Popovic M, Gartner S, McLean DM, McLeod WA, Read E, et al. Acute HIV infection presenting with painful swallowing and esophageal ulcers. JAMA 1990;263:2318-22.
15. Silver B, McAvoy K, Mikesell S, Smith TW. Fulminating encephalopathy with perivenular demyelination and vacuolar myelopathy as the initial presentation of human immunodeficiency virus infection. Arch Neurol 1997;54:647-50.
16. Calabrese LH, Proffitt MR, Levin KH, Yen-Lieberman B, Starkey C. Acute infection with the human immunodeficiency virus (HIV) associated with acute brachial neuritis and exanthematous rash. Ann Intern Med 1987;107:849-51.
17. Denning DW, Anderson J, Rudge P, Smith H. Acute myelopathy associated with primary infection with human immunodeficiency virus. BMJ 1987;294:143-4.
18. Wechsler AF, Ho DD. Bilateral Bell's palsy at the time of HIV seroconversion. Neurology 1989;39:747-8.
19. Paton P, Poly H, Gonnaud PM, Tardy JC, Fontana J, Kindbeiter K, et al. Acute meningoradiculitis concomitant with seroconversion to human immunodeficiency virus type 1. Res Virol 1990;141:427-33.
20. Hagberg L, Malmvall BE, Svennerholm L, Alestig K, Norkrans G. Guillain-Barré syndrome as an early manifestation of HIV central nervous system infection. Stand J Infect Dis 1986;18:591-2.
21. Hellerstein MK, Grunfeld C, Wu K, Christiansen M, Kaempfer S, Kletke C. et al. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab 1993;76:559-65.
22. Safrin S, Grunfeld C. Fat distribution and metabolic changes in patients with HIV infection. AIDS 1999;13:2493-505.
23. Brinkman K, Smeitink JA, Romijn JA, Reiss P. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet 1999;354:1112-5.
24. Macallan DC. Metabolic syndromes in human immunodeficiency virus infection. Horm Res 2001;55(suppl 1):36-41.
25. Brinkman K. Evidence for mitochondrial toxicity: lactic acidosis as proof of concept. J HIV Ther 2001;6:13-6.
26. McCarthy GM. Host factors associated with HIV-related oral candidiasis. A review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1992;73:181-6.
27. Patton LL. Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden. Oral Surg Oral Med Oral Patrol Oral Radiol Endod 2000;90:182-8.
28. Tappuni AR, Fleming GJ. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study. Oral Surg Oral Med Oral Patrol Oral Radiol Endod 2001;92:623-8.
29. Weinert M, Grimes RM, Lynch DP. Oral manifestations of HIV infection. Ann Intern Med 1996;125:485-96.
30. Cunningham ET Jr, Margolis TP. Ocular manifestations of HIV infection. N Engl J Med 1998 23;339:236-44.
31. Kuppermann BD, Petty JG, Richman DD, Mathews WC, Fullerton SC, Rickman LS, et al. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1993;115:575-82.
32. Berenguer J, Gonzalez J, Pulido F, Padilla B, Casado JL, Rubio R, et al. Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy. Clin Infect Dis 2002;34:394-7.
33. Whitcup SM. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. JAMA 2000;283:653-7.
34. Jensen BL, Weismann K, Sindrup JH, Sondergaard J, Schmidt K. Incidence and prognostic significance of skin disease in patients with HIV/AIDS: a 5-year observational study. Acta Derm Venereol 2000;80:140-3.
35. Zampogna JC, Flowers FP. Persistent verrucous varicella as the initial manifestation of HIV infection. J Am Acad Dermatol 2001;44:S391-4.
36. Colebunders R, Van Damme L, Van den Abbeele K, Fleerackers Y, Van den Enden E, Dockx P. Atypical varicella zoster infection in persons with HIV infection. Acta Clin Belg 1994;49:104-7.
37. Conant MA. The AIDS epidemic. J Am Acad Dermatol 1994;31:S47-50.
38. Lynch JL, Blickman JG, terMeulen DC, Babl FE, Moloney CH, Pelton SI. Radiographic resolution of lymphocytic interstitial pneumonitis (LIP) in children with human immunodeficiency virus (HIV): not a sign of clinical deterioration. Pediatr Radiol 2001;31:299-303.
39. Griffiths MH, Miller RF, Semple SJ. Interstitial pneumonitis in patients infected with the human immunodeficiency virus. Thorax 1995;50:1141-6.
40. Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA. HIV-related pulmonary hypertension: analytic review of 131 cases. Chest 2000;118:1133-41.
41. Pellicelli AM, Palmieri F, D'Ambrosio C, Rianda A, Boumis E, Girardi E. Role of human immunodeficiency virus in primary pulmonary hypertension - case reports. Angiology 1998;49:1005-11.
42. Kaul S, Fishbein MC, Siegel RJ. Cardiac manifestations of acquired immune deficiency syndrome: a 1991 update. Am Heart J 1991;122:535-44.
43. Grody WW, Cheng L, Lewis W. Infection of the heart by the human immunodeficiency virus. Am J Cardiol 1990;66:203-6.
44. Rodriguez ER, Nasim S, Hsia J, Sandin RL, Ferreim A, Hilliard BA, et al. Cardiac myocytes and dendritic cells harbor human immunodeficiency virus in infected patients with and without cardiac dysfunction: detection by multiplex, nested, polymerase chain reaction in individually microdissected cells from right ventricular endomyocardial biopsy tissue. Am J Cardiol 1991;68:1511-20.
45. Herskowitz A, Willoughby SB, Vlahov D, Baughman KL, Ansari AA. Dilated heart muscle disease associated with HIV infection. Eur Heart J 1995;16(suppl O):50-5.
46. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-9.
47. Lai WW, Colan SD, Easley KA, Lipshultz SE, Starc TJ, Bricker JT, et al. P2C2 HIV Study Group, National Heart, Lung, and Blood Institute. Dilation of the aortic root in children infected with human immunodeficiency virus type 1: the Prospective P2C2 HIV Multicenter Study. Am Heart J 2001;141:661-70.
48. Keesler MJ, Fisher SD, Lipshultz SE. Cardiac manifestations of HIV infection in infants and children. Ann NY Acad Sci 2001;946:169-78.
49. Pugliese A, Isnardi D, Saini A, Scarabelli T, Raddino R, Torre D. Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect 2000;40:282-4.
50. Fantoni M, Autore C, Del Borgo C. Drugs and cardiotoxicity in HIV and AIDS. Ann N Y Acad Sci 2001;946:179-99.
51. Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985;313:1493-7.
52. Bacellar H, Munoz A, Miller EN, Cohen BA, Besley D, Selnes OA, et al. Temporal trends in the incidence of HIV-l-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. Neurology 1994;44:1892-900.
53. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN. et al. The Multicenter AIDS Cohort Study. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 2001;56:257-60.
54. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233:1089-93.
55. Fischer-Smith T, Croul S, Sverstiuk AE, Capini C, L'Heureux D, Regulier EG, et al. CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol 2001;7:528-41.
56. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 1992;176:1703-18.
57. Gardenswartz MH, Lerner CW, Seligson GR, Zabetakis PM, Rotterdam H, Tapper ML. Renal disease in patients with AIDS: a clinicopathologic study. Clin Nephrol 1984;21:197-204.
58. D'Agati V, Appel GB. Renal pathology of human immunodeficiency virus infection. Semin Nephrol 1998;18:406-21.
59. Lowe FC, Lattimer DG, Metroka CE. Kaposi's sarcoma of the penis in patients with acquired immunodeficiency syndrome. J Urol 1989;142:1475-7.
60. Hochberg MC, Fox R, Nelson KE, Saah A. HIV infection is not associated with Reiter's syndrome: data from the Johns Hopkins Multicenter AIDS Cohort Study. AIDS 1990;4:1149-51.
61. Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL, Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 1990;322:1098-105.
62. Bessen LJ, Greene JB, Louie E, Seitzman P, Weinberg H. Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC [letter]. N Engl J Med 1988;318:708.
63. Chetty R, Batitang S, Nair R. Large artery vasculopathy in HIV-positive patients: another vasculitic enigma. Hum Pathol 2000;31:374-9.
64. Maxson CJ, Greenfield SM, Turner JL. Acute pancreatitis as a common complication of 2′,3′-dideoxyinosine therapy in the acquired immunodeficiency syndrome. Am J Gastroenterol 1992;87:708-13.
65. Maury CP, Lahdervirta J. Correlation of serum cytokine levels with haematological abnormalities in human immunodeficiency virus infection. J Intern Med 1990;227:253-7.
66. Krantz SB. Pathogenesis and treatment of anemia of chronic disease. Am J Med Sci 1994;307:353-9.
67. Peltier JY, Lambin P, Doinel C. Frequency and prognostic importance of thrombocytopenia in symptom-free HIV-infected individuals: a 5-year prospective study. AIDS 1991;5:381-4.
68. Sloand EM, Klein HG, Banks SM, Vareldzis B, Merritt S, Pierce P. Epidemiology of thrombocytopenia in HIV infection. Eur J Haematol 1992; 8:168-72.
69. Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998;351:1833-9.
70. Jones JL, Hanson DL, Dworkin MS, Jaffe HW. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. J Acquir Immune Defic Syndr 2000;24:270-4.
71. Jones JL, Hanson DL, Dworkin MS, Ward JW, Jaffe HW. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult/Adolescent Spectrum of HIV Disease Project Group. J Acquir Immune Defic Syndr 1999;21:S11-7.
72. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of HHV8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996;2:918-24.
73. Biggar RJ, Frisch M, Goedert JJ. Risk of cancer in children with AIDS. AIDS-Cancer Match Registry Study Group. JAMA 2000;284:205-9.
74. Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000;I:S5-14.
75. Cheng VC, Yuen KY, Chan WM. Wong SS, Ma ES, Chan RM. Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 2000;30:882-92.
76. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-6.
77. Sleasman JW, Nelson RP, Goodenow MM, Wilfret D, Hutson A, Baseler M, et al. Immunoreconstitution after ritonavir therapy in children with human immunodeficiency virus infection involves multiple lymphocyte lineages. J Pediatr 1999;134:597-606.
78. Jacobson MA, Zegans M, Pavan PR, O'Donnell JJ, Sattler F, Rao N, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997;349:1443-5.
79. Phillips P, Kwiatkowski MB, Copland M, Craib K, Montaner J. Mycobacterial lymphadenitis associated with the initiation of combination antiretroviral therapy. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:122-8.
80. Elliot B, Aromin I, Gold R, Flanigan T, Mileno M. 2.5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy [letter]. Lancet 1997;349:850.
81. Parra R, Leal M, Delgado J, Macias J, Rubio A, Gomez F, et al. Regression of invasive AIDS-related Kaposi's sarcoma following antiretroviral therapy. Clin Infect Dis 1998;26:218-9.